23,99 €
inkl. MwSt.

Erscheint vorauss. 1. Mai 2025
payback
12 °P sammeln
  • Broschiertes Buch

Research shows the tremendous benefit of psychedelic drugs for people suffering from post-traumatic stress disorder (PTSD), depression, anxiety, and trauma. This workbook draws on evidence-based harm reduction techniques to help readers experiment with psychedelic substances--on their own, in a group, or with a therapist--and integrate the lessons they've learned from psychedelic experiences into daily life.

Produktbeschreibung
Research shows the tremendous benefit of psychedelic drugs for people suffering from post-traumatic stress disorder (PTSD), depression, anxiety, and trauma. This workbook draws on evidence-based harm reduction techniques to help readers experiment with psychedelic substances--on their own, in a group, or with a therapist--and integrate the lessons they've learned from psychedelic experiences into daily life.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Elizabeth Nielson, PhD, is a psychologist and cofounder of Fluence with an expertise in psychedelic therapist training. She has worked on developing psychedelic therapies through conduct of FDA-approved trials of psychedelics for PTSD, substance use problems, and mood disorders, and she has published research on psychedelic therapies and psychedelic therapist training. Nielson has also worked as an educator for clinicians for over a decade and continues to create training programs to ensure the highest quality care for psychedelic users. Ingmar Gorman, PhD, is a psychologist and cofounder of Fluence, specializing in psychedelic education for mental health providers. His extensive clinical training and experience includes prestigious institutions in New York City. Notably, Gorman contributes to FDA-approved clinical trials of psychedelic treatments, and has published extensively on psychedelics and harm reduction.